Giannoccaro M, Avoni P, Liguori R
Brain Sci. 2021; 11(8).
PMID: 34439654
PMC: 8392118.
DOI: 10.3390/brainsci11081035.
Wang X, Burke S, Talmadge R, Voss A, Rich M
J Gen Physiol. 2020; 152(5).
PMID: 32243496
PMC: 7201880.
DOI: 10.1085/jgp.201912526.
Rogers R, Nishimune H
Matrix Biol. 2016; 57-58:86-105.
PMID: 27614294
PMC: 5328857.
DOI: 10.1016/j.matbio.2016.08.008.
Ferrari R, Rodrigues-Simioni L, Hofling M
Molecules. 2012; 17(6):7503-22.
PMID: 22706376
PMC: 6268877.
DOI: 10.3390/molecules17067503.
Clarke G, Chen J, Nishimune H
Front Mol Neurosci. 2012; 5:12.
PMID: 22438837
PMC: 3305919.
DOI: 10.3389/fnmol.2012.00012.
Autoimmune channelopathies of the nervous system.
Kleopa K
Curr Neuropharmacol. 2012; 9(3):458-67.
PMID: 22379460
PMC: 3151600.
DOI: 10.2174/157015911796557966.
John Newsom-Davis: clinician-scientist and so much more.
Vincent A
Brain. 2011; 134(Pt 12):3755-74.
PMID: 22171357
PMC: 3235562.
DOI: 10.1093/brain/awr284.
New Ideas about Myasthenia Gravis.
Layzer R
Calif Med. 1970; 113(3):65-7.
PMID: 18730405
PMC: 1501539.
Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
Flink M, Atchison W
J Bioenerg Biomembr. 2004; 35(6):697-718.
PMID: 15000529
DOI: 10.1023/b:jobb.0000008033.02320.10.
Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
Flink M, Atchison W
J Physiol. 2002; 543(Pt 2):567-76.
PMID: 12205190
PMC: 2290502.
DOI: 10.1113/jphysiol.2002.021048.
Lambert-Eaton myasthenic syndrome.
Seneviratne U, De Silva R
Postgrad Med J. 2000; 75(887):516-20.
PMID: 10616683
PMC: 1741360.
DOI: 10.1136/pgmj.75.887.516.
Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.
Engisch K, Rich M, Cook N, Nowycky M
J Neurosci. 1999; 19(9):3384-95.
PMID: 10212298
PMC: 6782246.
Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
Satoh Y, Hirashima N, Tokumaru H, Takahashi M, Kang J, Viglione M
J Physiol. 1998; 508 ( Pt 2):427-38.
PMID: 9508807
PMC: 2230882.
DOI: 10.1111/j.1469-7793.1998.427bq.x.
Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons.
Garcia K, Mynlieff M, Sanders D, Beam K, Walrond J
Proc Natl Acad Sci U S A. 1996; 93(17):9264-9.
PMID: 8799189
PMC: 38630.
DOI: 10.1073/pnas.93.17.9264.
Reduction of calcium currents by Lambert-Eaton syndrome sera: motoneurons are preferentially affected, and L-type currents are spared.
Garcia K, Beam K
J Neurosci. 1996; 16(16):4903-13.
PMID: 8756422
PMC: 6579308.
Voltage-dependent sodium channels in human small-cell lung cancer cells: role in action potentials and inhibition by Lambert-Eaton syndrome IgG.
Blandino J, Viglione M, Bradley W, Oie H, Kim Y
J Membr Biol. 1995; 143(2):153-63.
PMID: 7731034
DOI: 10.1007/BF00234661.
Immunopathology of the Lambert-Eaton myasthenic syndrome.
Lang B, Newsom-Davis J
Springer Semin Immunopathol. 1995; 17(1):3-15.
PMID: 7482225
DOI: 10.1007/BF00194096.
Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome.
SMITH D, Conklin M, Jensen P, Atchison W
J Physiol. 1995; 487(1):115-23.
PMID: 7473242
PMC: 1156603.
DOI: 10.1113/jphysiol.1995.sp020865.
Cephalic tetanus studied with single fibre EMG.
Fernandez J, Ferrandiz M, Larrea L, Ramio R, Boada M
J Neurol Neurosurg Psychiatry. 1983; 46(9):862-6.
PMID: 6311990
PMC: 1027573.
DOI: 10.1136/jnnp.46.9.862.
Novel drug of choice in Eaton-Lambert syndrome.
LUNDH H, Nilsson O, Rosen I
J Neurol Neurosurg Psychiatry. 1983; 46(7):684-5.
PMID: 6310051
PMC: 1027495.
DOI: 10.1136/jnnp.46.7.684.
